A critical issue in photodynamic therapy (PDT) is inadequate reactive oxygen species (ROS)
generation in tumors, causing inevitable survival of tumor cells that usually results in tumor …

Iridium (III) complexes are an important group of photosensitizers for photodynamic therapy
(PDT). This work constructs a donor–acceptor–donor structure‐based iridium (III) complex …

Iridium (III) complexes are potent candidates for photodynamic therapy. However, their
clinical usage is impeded by their poor water solubility, high dark toxicity, and negligible …

Phototherapy as a promising cancer diagnostic and therapeutic strategy has aroused
extensive attention. However, single‐wavelength near‐infrared (NIR) light–triggered …

Melanoma represents the most fatal form of skin cancer due to its resistance mechanisms
and high capacity for the development of metastases. Among other medicinal techniques …

The utilization of photodynamic therapy (PDT) for the treatment of various types of cancer
has gained increasing attention over the last decades. Despite the clinical success of …

For photodynamic therapy (PDT), traditional type II photosensitizers rely on local molecular
oxygen to produce highly cytotoxic singlet oxygen (1 O 2) to kill tumor cells, which is …

Effective photosensitizers are of particular importance for the widespread clinical utilization
of phototherapy. However, conventional photosensitizers are usually plagued by short …

Photodynamic therapy (PDT) represents a promising approach for cancer treatment.
However, the oxygen dependency of PDT to generate reactive oxygen species (ROS) …

Mounting evidence over the past 20 years suggests that photodynamic therapy (PDT), an
anticancer modality known mostly as a local treatment, has the capacity to invoke a systemic …